What Promega does

Promega Corporation is a privately held life sciences tools company founded in 1978 and headquartered in Madison, Wisconsin, that develops, manufactures, and globally distributes proprietary reagents, assay kits, instruments, and molecular diagnostic products. The company's core technology stack is anchored on its proprietary NanoLuc luciferase platform — a small, extremely bright bioluminescent enzyme — and a family of derived platforms including NanoBRET (for live-cell target engagement measurement), HiBiT (an 11-amino-acid protein tagging system), HaloTag (covalent protein labeling), and LumIt (bioluminescent immunoassays). Hardware products include GloMax Discover multimode microplate readers, Maxwell RSC automated nucleic acid purification systems, the Maxprep liquid handler, Spectrum CE capillary electrophoresis instruments, and Quantus fluorometers, with SiLA2-compliant lab automation integration. The commercial business sells research reagents and consumables, instruments, custom manufacturing services (including lyophilized PCR master mixes and mRNA manufacturing raw materials), molecular diagnostic kits (notably the OncoMate MSI Dx Analysis System, FDA-approved in November 2025 as a companion diagnostic for KEYTRUDA plus LENVIMA, and NMPA-approved in China in February 2026), and forensic DNA analysis products.

Promega serves five primary customer segments — pharmaceutical and biotechnology drug discovery, molecular diagnostics and clinical research, forensic science and human identification, applied sciences/One Health, and academic education — across more than 25 countries through a combination of direct field sales, a global distributor network, a catalog-based e-commerce storefront, and dedicated Technical Services Scientists. The company operates on a quote-based pricing model with account-based catalog pricing, one-time reagent sales, hardware sales, and custom services revenue, and has no disclosed outside funding rounds, suggesting it is founder-owned and self-financed under chairman and CEO William Linton. Recent strategic actions — MilliporeSigma co-development for organoid-based drug screening (October 2025), FDA and NMPA approvals of the OncoMate MSI platform, the TarSeer BRETSA Target Engagement System launch at SLAS 2026 (February 2026), and a NimaGen forensic MPS distribution agreement (April 2026) — signal an active expansion phase into companion diagnostics, 3D cell-culture drug discovery, and next-generation forensic sequencing.

Name

Promega

Legal name

Promega Corporation

Website

https://promega.com

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Promega Corporation is a privately held Madison, Wisconsin life sciences company manufacturing proprietary bioluminescent reagents, NanoBRET and HaloTag assay platforms, instruments, and FDA/NMPA-approved molecular diagnostic kits for pharmaceutical, academic, forensic, and clinical research customers worldwide.

Ownership category

akta.pro rank

Product category

Life Sciences Research Reagents and Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI)

akta.pro secondary industries

Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB), Proteomics & Biomarker Analytical Testing (HLAGADAG), Forensic & Anti-Counterfeit Testing (Product Integrity) (HLAGADAM)

Keywords

• Life sciences reagents
• Molecular biology assays
• Bioluminescence technology
• Forensic DNA analysis
• Molecular diagnostics kits

Headquarters

HQ city

Madison

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Research Reagents and Consumables: Sale of biological reagents including luciferase assays, PCR systems, RNA extraction kits, and cell biology reagents for research laboratories
2. Laboratory Instruments: Sale of specialized laboratory instruments including GloMax plate readers, Maxwell automated purification systems, and Spectrum CE Systems
3. Molecular Diagnostics: Sale of diagnostic kits including OncoMate MSI Detection Kit for companion diagnostics in oncology
4. Custom Manufacturing Services: Custom manufacturing capabilities including lyophilized PCR master mixes, mRNA manufacturing raw materials, and tailored R&D solutions
5. Forensic DNA Analysis Products: Kits and instruments for forensic DNA analysis supporting law enforcement and forensic laboratories

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Core offering

Promega Corporation develops and manufactures biological research reagents, assay kits, laboratory instruments, and molecular diagnostic products for life science research, drug discovery, forensic human identification, and clinical diagnostics. Its portfolio centers on proprietary NanoLuc luciferase-based bioluminescence platforms and includes nucleic acid extraction systems, PCR reagents, transfection reagents, plate readers, and companion diagnostic kits such as the OncoMate MSI Detection System.

Product overview

Promega Corporation is a life sciences reagent and instrument company offering a broad portfolio of bioluminescent technologies, assays, instruments, and molecular biology tools. The core technology platform centers on NanoLuc Luciferase and NanoBRET Target Engagement technology, which power products for drug discovery target engagement studies (NanoBRET TE K192 Kinase Selectivity System, TarSeer BRETSA System), cell biology assays, and protein analysis. The product portfolio includes: GoTaq Probe qPCR/RT-qPCR Systems for nucleic acid amplification; ReliaPrep RNA Miniprep and Maxwell RSC automated purification systems for sample preparation; GloMax Discover multimode plate readers and Quantus Fluorometer for detection; FuGENE HD transfection reagents for cellular delivery; QuantiFluor RNA Systems for quantitation; Water-Glo ATP testing for environmental monitoring; and forensic DNA analysis tools including OncoMate MSI Detection Kit and Spectrum CE Systems. Additional technology platforms include HaloTag protein labeling, HiBiT protein tagging, and Lumit bioluminescence immunoassays. The company offers custom manufacturing services including mRNA raw materials and assay development, distributed through global distribution agreements such as NimaGen IDseek MPS kits.

Differentiator

Problem solved

Functional benefit

Brands

• GloMax: Line of microplate readers and luminometers for luminescence, fluorescence, and absorbance detection
• GoTaq
• NanoLuc
• NanoBRET
• Maxwell
• ReliaPrep
• QuantiFluor
• FuGENE
• HaloTag
• Lumit

Products and services

• NanoBRET TE K192 Kinase Selectivity System Live-cell assay system profiling compound cellular selectivity against 192 human kinases in a single experiment, providing quantitative occupancy data using an addition-only protocol.
• GoTaq Probe qPCR and RT-qPCR Systems Ready-to-use 2X master mixes for quantitative PCR and RT-qPCR using hydrolysis probe detection, compatible with most real-time PCR instruments and resistant to PCR inhibitors.
• ReliaPrep RNA Miniprep Systems Membrane-based RNA purification system for extracting high-quality total RNA from cultured cells and tissue samples with on-column DNase treatment, processing 100 cells to 5 million cells per prep.
• GloMax Discover Microplate Reader Multimode microplate reader with luminescence, fluorescence, UV-visible absorbance, BRET and FRET detection capabilities for 6- to 384-well formats, optimized with Promega assay chemistries and SiLA2-compliant for lab automation integration.
• FuGENE HD Transfection Reagent Non-liposomal transfection reagent for delivering nucleic acids into eukaryotic cells with high efficiency and low toxicity, compatible with serum-containing media and difficult-to-transfect cell lines.
• QuantiFluor RNA System Fluorescent RNA-binding dye system for sensitive quantitation of small amounts of RNA, detecting as little as 100pg RNA with 0.1-500ng per microliter range.
• QuantiFluor RNA Select System Add-and-read fluorescent RNA quantitation system with broad dynamic range (16-1000ng per microliter), ideal for RNA sequencing template inputs with ambient shipping compatibility.
• Water-Glo System ATP bioluminescence-based microbial water testing kit providing low-level detection of all live microbes in minutes for industrial process, drinking water, wastewater, and environmental monitoring.
• Maxwell RSC simplyRNA Blood Kit Automated RNA purification kit for extracting total RNA from 2.5ml fresh whole blood samples using Maxwell RSC Instruments with low elution volume.
• pmirGLO Dual-Luciferase miRNA Target Expression Vector Reporter vector for quantitatively evaluating microRNA activity by inserting target sites downstream of firefly luciferase gene, with Renilla luciferase normalization.
• Dual-Glo Luciferase Assay System Homogeneous reagent system for consecutive detection of firefly and Renilla luciferase activities in a single sample with 2-hour extended signal half-life, using an add-mix-measure protocol.
• OncoMate MSI Detection Kit PCR-based microsatellite instability (MSI) detection assay for identifying MSI-High solid tumor patients as a companion diagnostic for KEYTRUDA immunotherapy.
• TarSeer BRETSA Target Engagement System Live-cell target engagement platform that detects ligand-protein interactions in intact cells using bioluminescence resonance energy transfer-based shift assay technology, addressing the gap between biochemical and cellular assays for drug discovery.
• Helix On-Site Stocking Service Onsite inventory management and stocking service providing convenient access to Promega products directly in laboratories.
• mRNA Manufacturing Raw Materials Custom manufacturing services for mRNA therapeutics research including raw materials for LNP and mRNA delivery applications.

Quantifiable outcome

• TarSeer BRETSA system applied to over 20 target classes
• +1 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature8 records

Partnerships

Six partnerships are on record, tiered minor and core.

• California State Polytechnic University, PomonaminorStrategic or Co-development Partner · 1 June 2026Promega contributed laboratory instrumentation to support Cal Poly's new Engineering Synthetic Cells course, combining coursework with research as a Course-based Undergraduate Research Experience (C.U.R.E.).
• NimaGencoreChannel Partner/ Reseller/ Distributor · 1 April 2026Distribution agreement for NimaGen's IDseek massively parallel sequencing kit portfolio. Promega distributes more than 20 products across seven product families, including autosomal and Y-chromosomal STR profiling kits, microhaplotype analysis, and mitochondrial DNA sequencing kits through its global distribution network.
• UBC RNA & Formulation CoreminorChannel Partner/ Reseller/ Distributor · 1 April 2026Authorization granted for UBC RNA & Formulation Core to distribute NanoLuc-Encoding mRNA for LNP and mRNA delivery research. Research supply arrangement supporting mRNA therapeutics research.
• Merck & Co. (MSD)coreStrategic or Co-development Partner · 1 February 2026Collaboration supporting regulatory approval of Promega's OncoMate MSI Detection Kit as companion diagnostic for KEYTRUDA (pembrolizumab). Promega partnered with Merck for China's NMPA approval of the MSI-High diagnostic assay for solid tumor patients.
• MilliporeSigma (Merck KGaA Life Science)coreStrategic or Co-development Partner · 1 October 2025Partnership to co-develop assay technologies capable of tracking cellular activity in real time within organoids. The collaboration aims to advance drug screening and discovery using 3D cell cultures, with plans to integrate Merck's Duolink with Promega's HiBiT technologies for enhanced cellular analysis.
• Merck KGaA (MilliporeSigma)coreStrategic or Co-development Partner · 1 October 2025Strategic partnership announced in October to co-develop organoid drug screening assays. The collaboration leverages Promega's assay technologies with MilliporeSigma's organoid models for more physiologically relevant drug discovery platforms.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Thermo Fisher Scientific: World's largest life sciences tools and diagnostics company, offering reagents, instruments, and molecular diagnostics. Directly comparable across Promega's portfolio, but at vastly greater scale and with broader catalog spanning everything from cell biology to clinical diagnostics.
• Merck KGaA / MilliporeSigma: Life science tools division of Merck KGaA offering biochemicals, reagents, and instruments. Active Promega partner on organoid drug screening; broad catalog competes across many of Promega's product lines from a position of greater scale.
• Agilent Technologies: Analytical instruments and life sciences tools company with comparable offerings in PCR/qPCR, nucleic acid analysis, and cell analysis. Broader portfolio spanning chromatography and mass spectrometry, with significantly larger revenue base than Promega.
• Revvity (formerly PerkinElmer): Life sciences and diagnostics company with overlapping reagents, cell-based assays, and molecular diagnostics. Comparable in life sciences applications segment but operates broader analytical instruments portfolio.

Direct peers

• Bio-Rad Laboratories: Public life sciences tools company with overlapping product lines in PCR/qPCR reagents (similar to GoTaq), digital PCR, protein analysis (Western blot), and clinical diagnostics. Closely comparable in scale, business model, and customer base to Promega.
• Bio-Techne: Research reagents and diagnostics company with comparable portfolio in proteins, antibodies, ELISA/immunoassays (similar to Lumit), and cell/gene therapy workflow tools. Direct competitor in research reagents for drug discovery and academic markets.
• QIAGEN: Molecular diagnostics and sample preparation specialist with overlapping products in nucleic acid extraction (similar to Maxwell), PCR, and companion diagnostics. Identified in the company data as a Promega competitor, with comparable scale and global footprint.
• Abcam: Research reagent company specializing in antibodies and immunoassay tools, recently acquired by Danaher. Direct competitor in immunoassay reagents and protein detection — comparable to Promega's Lumit and HaloTag platforms for academic and pharma research customers.

Emerging players

• GenScript: Biotechnology reagent and service company with comparable offerings in gene synthesis, protein production, and cell therapy reagents. Overlaps with Promega's nucleic acid and protein analysis tools, particularly for synthetic biology and cell/gene therapy customers.
• Promocell: Specialty provider of primary cells, cell culture reagents, and cell-based assays with overlapping offerings in cell biology research. Comparable target customer base (academic and pharma researchers) but narrower product portfolio than Promega.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/PromegaVideo
• Facebookfacebook.com/PromegaCorporation
• LinkedInlinkedin.com/company/promega
• Instagraminstagram.com/explore/locations/1670131
• Xx.com/promega

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Promega